MATTHEW ADLER: Open Payments
NPI 1033293659 · BRIGHTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,191 in 358 payments from 21 companies in 2025. Trend: 2023 $4,231 · 2024 $4,796 · 2025 $5,191
Food & beverage: $5,029Education: $162
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 77 | $1,060 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 51 | $849 |
| ABBVIE INC. | 34 | $440 |
| UCB, Inc. | 12 | $401 |
| Galderma Laboratories, L.P. | 32 | $349 |
| Novartis Pharmaceuticals Corporation | 21 | $334 |
| E.R. Squibb & Sons, L.L.C. | 40 | $309 |
| Incyte Corporation | 21 | $275 |
| GENZYME CORPORATION | 10 | $265 |
| PFIZER INC. | 19 | $191 |
Products named: TREMFYA, ILUMYA, Bimzelx, DUPIXENT, NEMLUVIO, Sotyktu, OPZELURA, RINVOQ.
Industry payments across MI — which companies pay providers there.
